Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rondelli

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|September 19, 2006
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationS Chunduri, L C Dobogai, D Peace, et al.
Leukemia|May 1, 1997
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year surveyF Lauria, D Rondelli, P L Zinzani, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Bone Marrow Transplantation|June 30, 1998
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phaseA Bonini, G Bandini, G Rosti, et al.
Bone Marrow Transplantation|July 1, 1996
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantationF Lauria, D Raspadori, M A Ventura, et al.
International Journal of Immunopathology and Pharmacology|September 17, 2005
Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathwayL Bonsi, L Pierdomenico, M Biscardi, et al.
Blood|February 15, 1997
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factorR M Lemoli, A Tafuri, A Fortuna, et al.
Haematologica|December 10, 1999
Cell therapy: achievements and perspectivesC Bordignon, C Carlo-Stella, M P Colombo, et al.
European Journal of Haematology|January 26, 1999
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantationP L Tazzari, D Rondelli, F Re, et al.
Bone Marrow Transplantation|June 23, 2009
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenR Beri, S Chunduri, K Sweiss, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|September 19, 2006
Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationS Chunduri, L C Dobogai, D Peace, et al.
Leukemia|May 1, 1997
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year surveyF Lauria, D Rondelli, P L Zinzani, et al.
Bone Marrow Transplantation|November 18, 1998
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cellsD Rondelli, D Raspadori, C Anasetti, et al.
Bone Marrow Transplantation|June 30, 1998
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phaseA Bonini, G Bandini, G Rosti, et al.
Bone Marrow Transplantation|July 1, 1996
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantationF Lauria, D Raspadori, M A Ventura, et al.
International Journal of Immunopathology and Pharmacology|September 17, 2005
Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathwayL Bonsi, L Pierdomenico, M Biscardi, et al.
Blood|February 15, 1997
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factorR M Lemoli, A Tafuri, A Fortuna, et al.
Haematologica|December 10, 1999
Cell therapy: achievements and perspectivesC Bordignon, C Carlo-Stella, M P Colombo, et al.
European Journal of Haematology|January 26, 1999
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantationP L Tazzari, D Rondelli, F Re, et al.
Bone Marrow Transplantation|June 23, 2009
Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimenR Beri, S Chunduri, K Sweiss, et al.
Pageof 8